We are live on
!
Find out more
NC
Noked Capital Portfolio holdings
AUM
$946K
1-Year Est. Return
17.1%
This Fund
S&P 500
This Quarter
Est. Return
+32.73%
1 Year Est. Return
-17.1%
3 Year Est. Return
+197.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$81.6M
AUM Growth
-$14.3M
(-15%)
Cap. Flow
-$32.4M
Cap. Flow
% of AUM
-39.71%
Top 10 Holdings %
Top 10 Hldgs %
71.77%
Holding
105
New
34
Increased
2
Reduced
37
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
|
+$1.6M |
| 2 |
BWAY
Brainsway
BWAY
|
+$568K |
| 3 |
Amazon
AMZN
|
+$466K |
| 4 |
JPMorgan Chase
JPM
|
+$452K |
| 5 |
Alibaba
BABA
|
+$380K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$12.1M |
| 2 |
SolarEdge
SEDG
|
+$6.42M |
| 3 |
Viatris
VTRS
|
+$5.67M |
| 4 |
Delek US
DK
|
+$1.35M |
| 5 |
Royal Bank of Canada
RY
|
+$605K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 58.02% |
| 2 | Energy | 11.29% |
| 3 | Healthcare | 7.68% |
| 4 | Communication Services | 6% |
| 5 | Financials | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
U-Haul Holding Co
UHAL
$14B
| – | – |
-11,000
| Closed | -$409K |
|
102
Universal Corp
UVV
$1.3B
| – | – |
-5,000
| Closed | -$288K |
|
|
103
Viatris
VTRS
$20.5B
| – | – |
-200,000
| Closed | -$5.67M |
|
|
KSU
104
DELISTED
Kansas City Southern
KSU
| – | – |
-3,800
| Closed | -$441K |
|
|
RTN
105
DELISTED
Raytheon Company
RTN
| – | – |
-2,600
| Closed | -$473K |
|
Similar funds
MC
GAM
NP
TGI
IVAV
VM
SC
CL
Noked Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Noked Capital held 105 positions worth $81.6M, down 15% from $95.9M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Noked Capital withdrew a net $32.4M in Q2 2019, closing 24 positions and reducing 37 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $12.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 58% of assets, up from 39% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Noked Capital opened a new position in Gamida Cell Ltd. Ordinary Shares worth $1.03M.
- Noked Capital's largest Q2 2019 buy was Gamida Cell Ltd. Ordinary Shares: 203,748 shares worth $1.03M.
- Noked Capital added most to Alphabet (Google) Class A in Q2 2019, an estimated $174K increase.
- Noked Capital's biggest Q2 2019 reduction was SolarEdge, cutting an estimated $6.42M.
- Noked Capital fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $12.1M.
- Noked Capital's ten largest holdings make up 72% of its $81.6M portfolio in Q2 2019.
- Noked Capital opened 34 new positions and closed 24 in Q2 2019.
- Noked Capital's portfolio value fell 15% quarter-over-quarter to $81.6M.
Based on Noked Capital's 13F filing for Q2 2019, filed 15 Aug 2019.